Formulation of human antibodies for treating TNF-alpha associated disorders | Patent Number 09750808

US 09750808 B2
Application Number15418460
Publication NumberUS 20170151329 A1
Pendency7 months, 11 days
Filled DateJan 27, 2017
Priority DateAug 16, 2002
Publication DateJun 1, 2017
Expiration DateAug 16, 2022
Inventor/ApplicantsLisa Baust
Michael Dickes
Hans-Juergen Krause
ExaminesBUNNER, BRIDGET E
Art Unit1647
Technology Center1600
Assignments
Abbvie Inc.
Current
Abbvie BiotechnologyAbbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.